chloramphenicol has been researched along with digoxin in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (53.33) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brish, M; Feigl, A; Feigl, D; Rotem, J; Shem-Tov, A | 1 |
| Lovering, EG; McGilveray, IJ; McMillan, I; Tostowaryk, W | 1 |
| Watson, AD | 1 |
| Buchanan, N | 1 |
| Chin, TF; Lach, JL; McCallister, JD | 1 |
| Harley, JD; Housego, CJ; Menser, MA; Murphy, AM | 1 |
| Macmillan, AL | 1 |
| Mokgokong, ET | 1 |
| Johnsgård, M; Pedersen, AO | 1 |
| Kurnick, JE; Malinow, SH; Snyderman, MC | 1 |
| Costello, JM; Shannon, FT | 1 |
| Zenk, KE | 1 |
| Buchmann, E; Fuchs, G; Fürst, W; Neubert, R; Stütz, B | 1 |
| ANDERSON, WR; HENDRY, WS; HUNEYCUTT, HC | 1 |
| BENNET, NM; STEVENSON, WJ | 1 |
| SILBERSTEIN, EB | 1 |
4 review(s) available for chloramphenicol and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bioavailability and bioinequivalence of drug formulations in small animals.
Topics: Animals; Aspirin; Biological Availability; Cats; Chloramphenicol; Digoxin; Dogs; Fenbendazole; Mitotane; Oxytetracycline; Penicillins; Phenytoin; Theophylline; Therapeutic Equivalency; Thyroxine | 1992 |
Therapeutic drug monitoring in childhood.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbamazepine; Child; Chloramphenicol; Digoxin; Drug Interactions; Half-Life; Humans; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Saliva; Theophylline; Valproic Acid | 1986 |
An overview of perinatal clinical pharmacology.
Topics: Abnormalities, Drug-Induced; Analgesics; Bupivacaine; Carbamazepine; Chloramphenicol; Diazepam; Digoxin; Female; Fetus; Furosemide; Gentamicins; Humans; Indomethacin; Infant, Newborn; Infant, Newborn, Diseases; Lidocaine; Penicillins; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Tetracycline; Theophylline | 1981 |
26 other study(ies) available for chloramphenicol and digoxin
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Congenital atrial flutter.
Topics: Atrial Flutter; Chloramphenicol; Chloroquine; Digoxin; Electrocardiography; Female; Fetal Diseases; Fetal Heart; Follow-Up Studies; Humans; Infant, Newborn; Infant, Newborn, Diseases; Malaria; Pregnancy; Pregnancy Complications, Infectious | 1975 |
Comparative bioavailabilities from truncated blood level curves.
Topics: Acetaminophen; Aminosalicylic Acids; Biological Availability; Biopharmaceutics; Chloramphenicol; Chlordiazepoxide; Digoxin; Humans; Isoniazid; Kinetics; Pharmaceutical Preparations; Phenylbutazone; Sulfamethizole; Tetracycline; Time Factors; Warfarin | 1975 |
Diffuse reflectance studies of solid-solid interactions. IV. Interaction of bishydroxycoumarin, furosemide, and other medicinal agents with various adjuvants.
Topics: Aluminum; Biopharmaceutics; Chloramphenicol; Dicumarol; Digoxin; Ergonovine; Furosemide; Indomethacin; Infrared Rays; Iron; Magnesium; Methods; Pharmaceutic Aids; Spectrophotometry; Spectrum Analysis; Zinc | 1970 |
Biological availability of drugs.
Topics: Biopharmaceutics; Chloramphenicol; Digoxin; Griseofulvin; Oxytetracycline; Phenindione; Spironolactone | 1972 |
Possible chemical factors in the postnatal development of rubella cataracts.
Topics: Birth Weight; Cataract; Cesarean Section; Chloramphenicol; Digoxin; Drug-Related Side Effects and Adverse Reactions; Ductus Arteriosus, Patent; Female; Humans; Infant; Infant, Newborn; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Rubella virus | 1966 |
Generalised pustular drug rash.
Topics: Adult; Aged; Biguanides; Chloramphenicol; Chloroquine; Cross Reactions; Digoxin; Drug Eruptions; Furosemide; Heart Failure; Humans; Malaria; Male; Mastoiditis; Middle Aged; Piperazines; Pruritus Ani; Pyrimethamine; Skin Manifestations | 1973 |
Treatment of septicaemic shock in gynaecology and obstetrics.
Topics: Abortion, Septic; Adrenal Cortex Hormones; Bicarbonates; Blood Transfusion; Chloramphenicol; Digoxin; Escherichia coli Infections; Exchange Transfusion, Whole Blood; Female; Gentamicins; Humans; Hysterectomy; Isoproterenol; Kanamycin; Penicillins; Plasma Substitutes; Pregnancy; Puerperal Infection; Sepsis; Shock, Septic; Tetracycline | 1973 |
[The consequence of the preparation factors for the effect of the drug].
Topics: Absorption; Administration, Oral; Biopharmaceutics; Capsules; Chemistry, Pharmaceutical; Chloramphenicol; Digoxin; Humans; Nitrofurantoin; Pharmaceutical Preparations; Pharmaceutical Vehicles; Phenytoin; Structure-Activity Relationship; Suppositories; Tablets; Tablets, Enteric-Coated; Tetracycline; Time Factors; Tolbutamide | 1973 |
Disseminated intravascular coagulation in Rocky Mountain spotted fever.
Topics: Adult; Afibrinogenemia; Blood Cell Count; Blood Platelets; Body Temperature; Chloramphenicol; Digoxin; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Heparin; Humans; Hydrocortisone; Male; Penicillins; Rocky Mountain Spotted Fever; Thrombocytopenia | 1974 |
Drugs and children.
Topics: Aminophylline; Aspirin; Atropine; Cardiomyopathies; Cataract; Child, Preschool; Chloramphenicol; Chlorothiazide; Conjunctivitis; Digoxin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Iatrogenic Disease; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male; Ophthalmic Solutions; Pre-Eclampsia; Pregnancy; Purpura, Thrombocytopenic; Substance-Related Disorders; Suppositories | 1968 |
[Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it].
Topics: Absorption; Biological Availability; Chloramphenicol; Digoxin; Half-Life; Models, Biological; Pharmaceutical Preparations; Phenytoin | 1982 |
PNEUMOCYSTIS CARINII PNEUMONIA. CASE STUDIES WITH ELECTRON MICROSCOPY.
Topics: Chlorambucil; Chloramphenicol; Cytomegalovirus Infections; Diagnosis, Differential; Digoxin; Electrons; Hodgkin Disease; Humans; Hydrocortisone; Infant; Lung Diseases; Mechlorethamine; Microscopy; Microscopy, Electron; Neoplasms; Pathology; Penicillins; Plasma Cells; Pneumonia; Pneumonia, Pneumocystis; Streptomycin | 1964 |
A CASE OF HUMAN BOTULISM DUE TO HOME-PRESERVED CANTALOUPE.
Topics: Botulism; Chloramphenicol; Cucumis melo; Digoxin; Diuretics; Food Preservation; Fruit; Humans; Neostigmine; Organomercury Compounds; Oxygen Inhalation Therapy; Penicillins | 1964 |
ERYSIPELOTHRIX ENDOCARDITIS: REPORT OF A CASE WITH CEREBRAL MANIFESTATIONS.
Topics: Brain Diseases; Chloramphenicol; Chlorothiazide; Digoxin; Diuretics; Drug Therapy; Endocarditis; Endocarditis, Bacterial; Erysipelothrix; Heart Failure; Heart Valve Diseases; Humans; Methicillin; Organomercury Compounds; Penicillin V; Penicillins; Probenecid; Sepsis | 1965 |